Hepatitis B and C virus infection is a risk factor for the development of cholangiocarcinoma

Internal Medicine

Volumn 53, Issue 7, 2014, Pages 651-654

  Matsumoto, Kazuya ^a   Onoyama, Takumi ^a   Kawata, Soichiro ^a   Takeda, Yohei ^a   Harada, Kenichi ^a   Ikebuchi, Yuichiro ^a   Ueki, Masaru ^a   Miura, Norimasa ^b   Yashima, Kazuo ^a   Koda, Masahiko ^a   Sakamoto, Teruhisa ^a   Endo, Masanori ^a   Horie, Yasushi ^a   Murawaki, Yoshikazu ^a  

^a TOTTORI UNIVERSITY HOSPITAL   (Japan)

^b TOTTORI UNIVERSITY   (Japan)

Author keywords

Cholangiocarcinoma; Hepatitis B virus; Hepatitis C virus

Indexed keywords

HEPATITIS B CORE ANTIGEN; HEPATITIS B SURFACE ANTIGEN; HEPATITIS C ANTIBODY;

ADULT; AGED; ARTICLE; BILE DUCT CARCINOMA; COMPUTER ASSISTED TOMOGRAPHY; ECHOGRAPHY; FEMALE; HEPATITIS B; HEPATITIS C; HUMAN; MAJOR CLINICAL STUDY; MALE; OBSTRUCTIVE JAUNDICE; PREVALENCE; RISK FACTOR; BILE DUCT NEOPLASMS; CHOLANGIOCARCINOMA; COMPLICATION; FOLLOW UP; HEPACIVIRUS; HEPATITIS B VIRUS; HEPATITIS C, CHRONIC; IMMUNOLOGY; INTRAHEPATIC BILE DUCT; JAPAN; MIDDLE AGED; VERY ELDERLY; VIROLOGY;

ADULT; AGED; AGED, 80 AND OVER; BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CHOLANGIOCARCINOMA; FEMALE; FOLLOW-UP STUDIES; HEPACIVIRUS; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HEPATITIS C ANTIBODIES; HEPATITIS C, CHRONIC; HUMANS; JAPAN; MALE; MIDDLE AGED; PREVALENCE; RISK FACTORS; SEROEPIDEMIOLOGIC STUDIES;

EID: 84897445546     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.53.1410     Document Type: Article

References (19)

1. Hsing AW, Zhang M, Rashid A, et al. Hepatitis B and C virus infection and the risk of biliary tract cancer: A population-based study in China. Int J Cancer 122: 1849-1853, 2008.
2. de Groen PC, Gores GJ, LaRusso NF, Gunderson LL, Nagorney DM. Biliary tract cancers. New Engl J Med 341: 1368-1378, 1999.
3. Nath G, Singh H, Shukla VK. Chronic typhoid carriage and carcinoma of the gallbladder. Eur J Cancer Prev 6: 557-559, 1997.
4. Haswell-Elkins MR, Mairiang E, Mairiang P, et al. Cross-sectional study of Opisthorchis viverrini infection and cholangiocarcinoma in communities within a high-risk area in northeast Thailand. Int J Cancer 59: 505-509, 1994.
5. Kobayashi T, Harada K, Miwa K, Nakanuma Y. Helicobacter genus DNA fragments are commonly detectable in bile from patients with extrahepatic biliary diseases and associated with their pathogenesis. Dig Dis Sci 50: 862-867, 2005.
6. Palmer WC, Patel T. Are common factors involved in the pathogenesis of primary liver cancers? A meta-analysis of risk factors for intrahepatic cholangiocarcinoma. J Hepatol 57: 69-76, 2012.
7. Zhou Y, Zhao Y, Li B, et al. Hepatitis viruses infection and risk of intrahepatic cholangiocarcinoma: evidence from a meta-analysis. BMC Cancer 12: 289, 2012.
8. Yin F, Chen B. Detection of hepatitis C virus RNA sequences in hepatic portal cholangiocarcinoma tissue by reverse transcription polymerase chain reaction. Chin Med J 111: 1068-1070, 1998.
9. Wang WL, Gu GY, Hu M. Expression and significance of HBV genes and their antigens in human primary intrahepatic cholangiocarcinoma. World J Gastroenterol 4: 392-396, 1998.
10. Shaib YH, El-Serag HB, Nooka AK, et al. Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: a hospital-based case-control study. Am J Gastroenterol 102: 1016-1021, 2007.
11. Tanaka J, Kumagai J, Katayama K, et al. Sex-and age-specific carriers of hepatitis B and C viruces in Japan estimated by the prevalence in the 3,485,648 first-time blood donors during 1995-2000. Interviology 47: 32-40, 2004.
12. Tottori prefecture health promoting council. Tottori-ken gan kenshin jissekihoukokusyo [internet]. 2012 Mar: 56-64. Available from: http://www.kentaikyou.tottori.med.or.jp/docs/shuppanbutu/ 24.3jiseki.pdf (in Japanese).
13. Donato F, Gelatti U, Tagger A, et al. Intrahepatic cholangiocarcinoma and hepatitis C and B virus infection, alcohol intake, and hepatolithiasis: a case-control study in Italy. Cancer Causes Control 12: 959-964, 2001.
14. Welzel TM, Graubard BI, El-Serag HB, et al. Risk factors for intrahepatic and extrahepatic cholangiocarcinoma in the United States: a population-based case-control study. Clin Gastroenterol Hepatol 5: 1221-1228, 2007.
15. Torbenson M, Yeh MM, Abraham SC. Bile duct dysplasia in the setting of chronic hepatitis C and alcohol cirrhosis. Am J Surg Pathol 31: 1410-1413, 2007.
16. Wu TT, Levy M, Correa AM, et al. Biliary intraepithelial neoplasia in patients without chronic biliary disease: analysis of liver explants with alcoholic cirrhosis, hepatitis C infection, and noncirrhotic liver diseases. Cancer 115: 4564-4575, 2009.
17. Chen RF, Li ZH, Zou SQ, et al. Effect of hepatitis C virus core protein on modulation of cellular proliferation and apoptosis in hilar cholangiocarcinoma. Hepatobiliary Pancreat Dis Int 4: 71-74, 2005.
18. Li T, Li D, Cheng L, et al. Epithelialmesenchymal transition induced by hepatitis C virus core protein in cholangiocarcinoma. Ann Surg Oncol 17: 1937-1944, 2010.
19. Lu H, Ye MQ, Thung SN, et al. Detection of hepatitis C virus RNA sequences in cholangiocarcinomas in Chinese and American patients. Chin Med J 113: 1138-1141, 2000.